Market Price

Price is unknown


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2017, it operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Equity (BVPS) 1.38
2.18
6.46
6.83
4.47
28.58
30.63
27.76
24.43
25.76
28.20
growth rate 58.0% 196.3% 5.7% -34.6% 539.4% 7.2% -9.4% -12.0% 5.4% 9.5%
Earnings BIT 944.90
1,210.00
1,310.00
1,910.00
2,020.00
2,190.00
3,030.00
4,679.10
5,024.20
5,129.00
5,536.80
growth rate 28.1% 8.3% 45.8% 5.8% 8.4% 38.4% 54.4% 7.4% 2.1% 8.0%
Avg.PE 32.15
17.73
27.78
24.45
17.67
30.21
30.40
32.12
19.10
12.98
12.74
growth rate -44.9% 56.7% -12.0% -27.7% 71.0% 0.6% 5.7% -40.5% -32.0% -1.9%
ROA 10.96
14.42
9.49
10.50
9.75
3.56
3.30
3.74
4.63
6.49
8.52
growth rate 31.6% -34.2% 10.6% -7.1% -63.5% -7.3% 13.3% 23.8% 40.2% 31.3%
ROE 62.35
87.47
35.75
33.00
41.97
10.15
8.16
9.58
13.23
20.26
26.30
growth rate 40.3% -59.1% -7.7% 27.2% -75.8% -19.6% 17.4% 38.1% 53.1% 29.8%
ROIC 23.77
29.43
18.53
19.04
17.50
6.78
5.85
6.85
8.36
12.09
15.28
growth rate 23.8% -37.0% 2.8% -8.1% -61.3% -13.7% 17.1% 22.0% 44.6% 26.4%
Cur. Ratio 0.80
0.75
0.76
0.75
1.48
0.82
0.64
0.62
0.70
0.75
0.67
growth rate -6.3% 1.3% -1.3% 97.3% -44.6% -22.0% -3.1% 12.9% 7.1% -10.7%
Quick Ratio 0.65
0.62
0.66
0.57
1.38
0.63
0.45
0.46
0.58
0.62
0.52
growth rate -4.6% 6.5% -13.6% 142.1% -54.4% -28.6% 2.2% 26.1% 6.9% -16.1%
Leverage 7.55
5.11
3.36
2.93
6.31
2.48
2.45
2.68
3.06
3.18
2.99
growth rate -32.3% -34.3% -12.8% 115.4% -60.7% -1.2% 9.4% 14.2% 3.9% -6.0%
Balance Sheet Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Acct.Receivable 1,155.90
2,516.40
1,720.90
1,961.50
5,826.40
4,478.30
5,979.80
6,721.30
7,062.10
7,056.30
growth rate 117.7% -31.6% 14.0% 197.0% -23.1% 33.5% 12.4% 5.1% -0.1%
Acct.Payable 1,584.10
4,531.80
4,882.20
11,625.50
12,849.50
12,712.60
13,944.20
growth rate 186.1% 7.7% 138.1% 10.5% -1.1% 9.7%
Cur.Assets 2,043.80
4,143.50
2,941.30
8,058.00
10,756.90
8,491.40
10,568.10
12,059.50
12,363.40
11,957.10
growth rate 102.7% -29.0% 174.0% 33.5% -21.1% 24.5% 14.1% 2.5% -3.3%
Total Assets 5,509.20
11,931.20
10,557.80
15,607.00
58,111.20
53,548.20
53,748.30
53,243.30
51,744.90
54,255.80
growth rate 116.6% -11.5% 47.8% 272.3% -7.9% 0.4% -0.9% -2.8% 4.9%
Cash 530.70
1,070.40
523.70
5,637.90
2,812.70
2,014.20
1,832.60
3,186.30
3,077.20
2,309.60
growth rate 101.7% -51.1% 976.6% -50.1% -28.4% -9.0% 73.9% -3.4% -24.9%
Inventory 203.00
313.00
382.40
374.40
1,652.10
1,871.10
2,113.20
2,023.10
1,959.00
2,124.90
growth rate 54.2% 22.2% -2.1% 341.3% 13.3% 12.9% -4.3% -3.2% 8.5%
Cur.Liabilities 2,721.70
5,456.80
3,917.20
5,458.10
13,057.40
13,235.30
17,012.60
17,155.30
16,428.10
17,846.40
growth rate 100.5% -28.2% 39.3% 139.2% 1.4% 28.5% 0.8% -4.2% 8.6%
Liabilities 4,431.00
8,379.40
6,951.20
13,133.30
34,726.20
31,710.80
33,684.30
35,862.80
35,501.10
36,130.50
growth rate 89.1% -17.0% 88.9% 164.4% -8.7% 6.2% 6.5% -1.0% 1.8%
LT Debt 1,760.00
1,340.30
2,492.50
2,493.70
7,076.40
14,980.10
12,363.00
10,966.40
13,946.30
14,846.00
14,981.50
growth rate -23.9% 86.0% 0.1% 183.8% 111.7% -17.5% -11.3% 27.2% 6.5% 0.9%
Equity 696.40
1,078.20
3,551.80
3,606.60
2,473.70
23,385.00
21,837.40
20,054.20
17,372.80
16,236.00
18,119.60
growth rate 54.8% 229.4% 1.5% -31.4% 845.4% -6.6% -8.2% -13.4% -6.5% 11.6%
Common Shares 528.00
504.00
532.00
544.00
505.00
747.00
822.00
759.00
695.00
631.00
583.00
growth rate -4.6% 5.6% 2.3% -7.2% 47.9% 10.0% -7.7% -8.4% -9.2% -7.6%
Cash Flow Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Capital Expenditures 75.00
85.80
147.50
119.90
144.40
160.20
423.00
436.60
295.90
330.40
267.40
growth rate 14.4% 71.9% -18.7% 20.4% 10.9% 164.0% 3.2% -32.2% 11.7% -19.1%
Cash Dividends 0.00
0.00
0.00
0.00
1.10
8.10
31.70
24.80
growth rate 636.4% 291.4% -21.8%
Cash From OA 827.30
1,103.00
1,771.50
2,117.40
2,193.10
4,781.60
4,757.50
4,549.00
4,848.30
4,919.40
5,351.30
growth rate 33.3% 60.6% 19.5% 3.6% 118.0% -0.5% -4.4% 6.6% 1.5% 8.8%
FCF per Share 1.42
2.02
3.05
3.67
3.49
6.18
5.09
5.27
6.50
8.00
10.02
growth rate 42.3% 51.0% 20.3% -4.9% 77.1% -17.6% 3.5% 23.3% 23.1% 25.3%
Sale Purchase of Stock -2,483.50
326.00
-3,589.20
510.50
183.10
87.20
81.00
growth rate 100.0% -100.0% 100.0% -64.1% -52.4% -7.1%
FCF 752.00
1,017.00
1,622.00
1,998.00
2,047.00
4,621.00
4,335.00
4,112.00
4,552.00
4,589.00
5,083.00
growth rate 35.2% 59.5% 23.2% 2.5% 125.7% -6.2% -5.1% 10.7% 0.8% 10.8%
Income Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Sales 21,820.00
21,978.00
24,722.30
44,973.20
46,128.30
93,714.30
104,098.80
100,887.10
101,751.80
100,287.50
100,064.60
growth rate 0.7% 12.5% 81.9% 2.6% 103.2% 11.1% -3.1% 0.9% -1.4% -0.2%
Op.Income 1,280.50
1,497.50
2,070.90
1,278.50
1,362.40
1,926.30
4,679.10
5,024.20
5,129.00
5,536.80
growth rate 17.0% 38.3% -38.3% 6.6% 41.4% 142.9% 7.4% 2.1% 8.0%
IBT 1,213.60
1,308.40
1,908.70
2,027.10
2,200.40
3,030.30
3,066.20
3,863.80
4,427.10
4,929.00
growth rate 7.8% 45.9% 6.2% 8.6% 37.7% 1.2% 26.0% 14.6% 11.3%
Net Income 776.10
827.60
1,181.20
1,278.50
1,362.40
1,926.30
2,007.60
2,476.40
3,404.40
4,517.40
growth rate 6.6% 42.7% 8.2% 6.6% 41.4% 4.2% 23.4% 37.5% 32.7%
EPS 1.07
1.54
1.56
2.17
2.53
1.76
2.25
2.64
3.56
5.39
7.74
growth rate 43.9% 1.3% 39.1% 16.6% -30.4% 27.8% 17.3% 34.9% 51.4% 43.6%
Gross Profit 1,758.80
2,040.90
2,424.00
2,958.20
3,209.90
7,311.90
8,132.40
8,387.40
8,619.90
8,620.50
8,767.10
growth rate 16.0% 18.8% 22.0% 8.5% 127.8% 11.2% 3.1% 2.8% 0.0% 1.7%

Quarterly Statements

Item Name Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Earnings BIT 1,478.40
1,625.20
1,014.70
1,378.80
1,542.80
growth rate 9.9% -37.6% 35.9% 11.9%
Balance Sheet Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Acct.Receivable 6,871.50
7,056.30
6,793.60
7,338.10
7,824.10
growth rate 2.7% -3.7% 8.0% 6.6%
Acct.Payable 13,861.40
13,944.20
13,926.80
14,685.00
14,603.10
growth rate 0.6% -0.1% 5.4% -0.6%
Cur.Assets 12,679.00
11,957.10
11,474.80
13,170.10
14,352.20
growth rate -5.7% -4.0% 14.8% 9.0%
Total Assets 51,206.20
54,255.80
53,405.60
54,677.80
55,441.60
growth rate 6.0% -1.6% 2.4% 1.4%
Cash 3,395.90
2,309.60
2,317.60
2,942.30
3,705.70
growth rate -32.0% 0.4% 27.0% 26.0%
Inventory 2,052.90
2,124.90
2,027.80
2,293.10
2,168.90
growth rate 3.5% -4.6% 13.1% -5.4%
Cur.Liabilities 17,356.80
17,846.40
16,723.10
18,586.70
18,691.40
growth rate 2.8% -6.3% 11.1% 0.6%
Liabilities 35,283.90
36,130.50
34,957.50
35,302.50
34,868.80
growth rate 2.4% -3.3% 1.0% -1.2%
LT Debt 13,726.70
14,981.50
14,900.50
13,457.60
12,974.20
growth rate 9.1% -0.5% -9.7% -3.6%
Equity 15,916.50
18,119.60
18,442.50
19,370.00
20,565.90
growth rate 13.8% 1.8% 5.0% 6.2%
Common Shares 8.60
8.60
8.70
8.70
8.70
growth rate 0.0% 1.2% 0.0% 0.0%
Cash Flow Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Capital Expenditures 72.00
90.10
100.40
75.40
65.50
growth rate 25.1% 11.4% -24.9% -13.1%
Cash Dividends
growth rate
Cash From OA 1,899.90
1,369.80
1,511.60
717.30
759.40
growth rate -27.9% 10.4% -52.6% 5.9%
Sale Purchase of Stock 13.80
29.70
82.30
23.90
growth rate 115.2% 177.1% -71.0%
FCF 1,827.90
1,279.70
1,411.20
641.90
693.90
growth rate -30.0% 10.3% -54.5% 8.1%
Income Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Sales 24,683.40
25,378.80
24,769.40
25,641.80
25,563.20
growth rate 2.8% -2.4% 3.5% -0.3%
Op.Income 1,478.40
1,625.20
1,014.70
1,378.80
1,542.80
growth rate 9.9% -37.6% 35.9% 11.9%
IBT 1,344.30
1,428.60
819.60
1,169.70
1,350.60
growth rate 6.3% -42.6% 42.7% 15.5%
Net Income 841.70
2,327.60
623.20
877.30
1,071.60
growth rate 176.5% -73.2% 40.8% 22.2%
EPS
growth rate
Gross Profit 2,237.70
2,495.50
1,895.10
2,241.50
2,358.60
growth rate 11.5% -24.1% 18.3% 5.2%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (68.54)

YOY Growth Grade:

D (48.26)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 10.69 10.69 9.76
EPS / Growth 14.1% 8.64 11.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 16.4%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 11.2% 13.9% 13.9%
Future PE 9.76 10.38 16.08
Future EPS 24.95 31.72 31.72
Value Price
MOS %
60.20
81.38
126.05
MOS Price 30.10 40.69 63.02
IRT

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.